![]() Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | Medicalsystem Biotechnology Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider. | Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers. | Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2003 | Founding Date 2008 | Founding Date 1995 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Miami, US HQ Woburn, US | Locations Ningbo Shi, CN HQ | Locations Hamburg, DE HQ Kobe, JP Baltimore, US | Locations San Diego, US HQ |
Employees | Employees 6,0967% increase | Employees 2,104 | Employees 65 | Employees 9735% increase |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 578.8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) ¥1.5b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $6.8m (FY, 2022) |
Cost of goods | Cost of goods $400.9m (FY, 2025) | Cost of goods ¥972.7m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $205.9m (FY, 2025) | Gross profit ¥547.3m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($225.7m) (FY, 2025) | Net income ¥61.4m (FY, 2025) | Net income N/A | Net income ($141.8m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 31m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 130m |
Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
View companySysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
View companyPrometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View company